Treerita Essalima Johnson-Greene bought $26k of OCGN
Chief Financial Officer at Ocugen, Inc.. 21,000 shares at an average of $1.23, traded Jun 15, 2026, filed Jun 17, 2026.
Score components
- +22RoleCFO
- +5Trade size$26k at market
- 0Relative to holdingsHoldings up 4.2%
- +8Price context51% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-043886, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | POpen-market purchase Common Stock | +21,000 | $1.23 | $26k | 521,000 | Jun 17, 2026 |
Related signals
Other insiders at Ocugen, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Oct 21, 2026 | Ocugen, Inc. | Shankar Musunuri Chief Executive Officer | $500k 525,991 shares | -12% | |
| 29Weak | Ocugen, Inc. | Shankar Musunuri Chief Executive Officer | $589k 525,991 shares | -11% | |
| 31Weak | Ocugen, Inc. | Prabhavathi Fernandes director | $9,095 10,000 shares | - | |
| 33Weak | Ocugen, Inc. | Kirsten Castillo director | $23k 25,000 shares | +50% | |
| 6Weak | Ocugen, Inc. | Shankar Musunuri Chief Executive Officer | $137k 95,809 shares | -11% | |
| 6Weak | Ocugen, Inc. | Shankar Musunuri Chief Executive Officer | $166k 100,000 shares | -12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.